Carboxylic acid salts
TARGETMOL CHEMICALS INC FOSTAMATINIB DISODIUM 10MG
Also available in 1 mg 2 mg 5 mg 25 mg 50 mg 100 mg 500 mg 1 mL 10 mM (in DMSO) and bulk. Please contact Fisher for quotes. Fostamatinib Disodium (R788 Disodium) is an orally available Syk kinase inhibitor with potential anti-inflammatory and immunomodulating activities. purity: 98%
Apexbio Technology LLC Azlocillin sodium salt 37091-65-9 5g
Azlocillin sodium salt (CAS 37091-65-9) is a small-molecule inhibitor targeting penicillin-binding proteins (PBPs) It is designed to inhibit bacterial cell wall synthesis thereby impeding cross-linking of peptidoglycan layers and inducing bacterial lysis Azlocillin sodium salt exerts its biological activity primarily through inhibition of PBPs disrupting cell wall integrity in bacteria In microbiological assays azlocillin demonstrates broad-spectrum antibacterial activity against both Gram-positive and Gram-negative bacteria reported IC50 values vary by microbial species and experimental conditions typically determined in minimum inhibitory concentration (MIC) assays Based on these pharmacological properties azlocillin sodium salt holds research potential in microbiological and biomedical investigations including studies of bacterial susceptibility resistance mechanisms and combinational antimicrobial therapies
Cambridge Isotope Laboratories SUCCINIC ACID, DISODIUM SALT (2,3-13C2, 99%), 1 G, 83587-80-8
SUCCINIC ACID, DISODIUM SALT (2,3-13C2, 99%), 1 G, 83587-80-8
eMolecules 3577-63-7 | 2-Amino-5-sulfobenzoic acid | Combi-Blocks | MFCD00035763 | 217.200 | C7H7NO5S | 95.000 | Nc1ccc(cc1C(O)=O)S(O)(=O)=O | 1g | 267202219
2-Amino-5-sulfobenzoic acid | Combi-Blocks | 3577-63-7 | MFCD00035763 | 217.200 | C7H7NO5S | 95.000 | Nc1ccc(cc1C(O)=O)S(O)(=O)=O | 1g | 267202219
Apexbio Technology LLC Cefonicid (sodium salt) 61270-78-8 10mM (in 1mL DMSO)
Cefonicid sodium salt (CAS 61270-78-8) is a second-generation cephalosporin antibiotic targeting penicillin-binding proteins (PBPs) It is designed to inhibit bacterial cell wall synthesis thereby exerting bactericidal effects against susceptible bacteria Cefonicid sodium salt acts through inhibition of bacterial cell wall synthesis by binding to PBPs In vitro studies indicate potent inhibition of pathogens such as Neisseria gonorrhoeae with minimal inhibitory concentration (MIC) values typically 2 g/mL Based on these pharmacological properties cefonicid sodium salt holds research potential for studying and treating urinary tract infections lower respiratory tract infections soft tissue infections osteomyelitis and uncomplicated gonorrhea
Medchemexpress LLC Sp-cAMPS sodium salt | 142439-95-0 | 99.5% | 367.25 | C10H11N5NaO5PS | 1 ML
Sp-cAMPS sodium salt is a cyclic AMP analog used in biochemical research to activate cAMP-dependent protein kinase A (PKA) isoforms and to probe cyclic nucleotide signaling. It exhibits inhibitory activity against phosphodiesterases and is supplied in solution or solid form for laboratory assays.
- Activates cAMP-dependent protein kinase A (PKA I and PKA II).
- Acts as a competitive phosphodiesterase inhibitor useful for signaling studies.
- Available as a ready-to-use 10 mM solution in DMSO or as a solid form.
- High purity suitable for biochemical and enzymatic assays.
- Enables reproducible modulation of cyclic nucleotide pathways in vitro.
Cayman Chemical PLC thioPIP2 sodium salt
A novel, chromogenic substrate for PLC; hydrolysis by PLC yields a free thiol which reacts with chromogenic reagents such as DTNB (Ellman’s reagent) to allow quantitation of PLC activity
Apexbio Technology LLC Rigosertib sodium salt 1225497-78-8 25mg
Rigosertib sodium salt (CAS 1225497-78-8) is a selective inhibitor targeting Polo-like kinase 1 (PLK1) with reported IC50 approximately 9 nM The compound notably decreases proliferation of cancer cell lines demonstrating nanomolar IC50 values in HeLa (115 nM) and C33A (45 nM) cells whereas normal cells (e g BJ and Ect1/E6E7) remain largely unaffected At concentrations exceeding 0 5 M rigosertib robustly induces G2/M phase arrest in cancer cells without significant cell cycle disruption at lower doses Additionally in vivo studies suggest its potential as a radiosensitizer in cervical carcinoma research
TARGETMOL CHEMICALS INC METHOTREXATE DISODIUM 500MG
Also available in 50 mg 100 mg 200 mg and bulk. Please contact Fisher for quotes. Methotrexate disodium is an tetrahydrofolate dehydrogenase inhibitorpurity: 99%
![Alkali Scientific NADH [B Nicotinamide adenine dinucleotide, reduced form, disodium salt], 1 G](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000661257.jpg-250.jpg)
Alkali Scientific NADH [B Nicotinamide adenine dinucleotide, reduced form, disodium salt], 1 G
NADH (Nicotinamide Adenine Dinucleotide, reduced form, disodium salt) is a coenzyme vital for biochemical research, particularly in cellular metabolism studies. This 1-gram quantity is commonly used in enzymatic reactions, redox processes, and assays that require a high-energy molecule. NADH plays a crucial role in energy transfer and cellular respiration, making it indispensable in studies related to mitochondrial function, metabolic diseases, and pharmacological research. The disodium salt form ensures better solubility in aqueous solutions, making it easier to handle and incorporate into experiments for accurate and reproducible results.
![eMolecules 41575-94-4 | Carboplatin | Broadpharm369.240 | C6H10N2O4Pt | 0.000 | [NH2-].[NH2-].[Pt+4].[O-]C(=O)C1(CCC1)C([O-])=O | 50mg | 573896669](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502458606.PNG-250.jpg)
eMolecules 41575-94-4 | Carboplatin | Broadpharm369.240 | C6H10N2O4Pt | 0.000 | [NH2-].[NH2-].[Pt+4].[O-]C(=O)C1(CCC1)C([O-])=O | 50mg | 573896669
Carboplatin | Broadpharm | 41575-94-4369.240 | C6H10N2O4Pt | 0.000 | [NH2-].[NH2-].[Pt+4].[O-]C(=O)C1(CCC1)C([O-])=O | 50mg | 573896669
Pfanstiehl Inc Dramamine Active EDGT (D-135) 5kg pack API, active pharmaceutical ingredient- CAS: 523-87-5
Dramamine Active EDGT (D-135) 5kg pack API, active pharmaceutical ingredient- CAS: 523-87-5
Medchemexpress LLC Tasurgratinib succinate | 1879965-80-6 | 99.2% | 764.8 g/mol | C32H37N5O6·3/2C4H6O4 | 50 MG
E7090 succinate (tasurgratinib succinate) is the succinate salt of tasurgratinib, an orally active small-molecule inhibitor selective for fibroblast growth factor receptors FGFR1-3. It is supplied as a high-purity research compound with documented solubility and in vivo formulation protocols for preclinical studies.
Cayman Chemical PLC thio-PIP2 (sodium salt), Purity: ≥98%, 1 mg
A novel, chromogenic substrate for PLC; hydrolysis by PLC yields a free thiol which reacts with chromogenic reagents such as DTNB (Ellman’s reagent) to allow quantitation of PLC activity